We have a Tier1 potash asset that has only advanced over the years as exploration has progressed. We have been a victim of our own success with the scale of the project and associated capital costs getting out of the reach of a small company. The declining potash market has added to our problems, in a sector that is out of favour with investors, leading to a prolonged decline in the share price.
Our projects are long life,high grade and low cost . All essential components of a successfull resource project.What we have lacked is a plausible path to development.
We missed the initial surge in the potash market,however,our major shareholders have kept us in the game to take advantage of the eventual upturn in the commodity cycle. They were long term players with patient capital.
I have been a shareholder since 2012 and the main reason for staying was the quality of the resource. As the years passed it appeared the most likely path to development was the selling of equity in the project or a takeover. SQM on the register being the catalyst. Sometime ago the board knocked back an in formal T/O bid by the chinese of around 30c. The latest sharemarket action would indicate the maybe someone has got wind of possible corporate activity. All speculation, but I am glad I doubled my shareholding a few weeks ago at 1.2c. Interesting that SQM recently announced a large capital raising for development purposes.
- Forums
- ASX - By Stock
- Ann: Correspondence received from the Minister of Mines
We have a Tier1 potash asset that has only advanced over the...
Featured News
Add KP2 (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.60M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
KP2 (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online